|
Phenotypic
Drug Susceptibility Testing Predicts Long-Term Virologic Suppression
Better than Treatment History in Patients with Human Immunodeficiency
Virus Infection [Call SA, et al. JID 2001;183:401]
posted 2/22/2001
Therapy
with Efavirenz plus Indinavir in Patients with Extensive Prior Nucleoside
Reverse-Transcriptase Inhibitor Experience: A Randomized, Double-Blind,
Placebo-Controlled Trial [Haas DW, et al. JID 2001;183:392]
posted 2/22/2001
Invasive
Fungal Sinusitis and Meningitis Due to Arthrographis kalrae
in a Patient with AIDS [Chin-Hong PV, et al. JCM
2001;39:804]
posted 2/22/2001
A
Randomized, Double-blind, Placebo-Controlled Trial of Psychostimulants
for the Treatment of Fatigue in Ambulatory Patients with Human Immunodeficiency
Virus Disease [Breitbart W, et al. Arch Intern Med
2001;161:411]
posted 2/22/2001
Excess
Mortality Due to Pneumonia or Influenza During Influenza A\Seasons
Among Persons with Acquired immunodeficiency Syndrome [Lin
JC, et al. Arch Intern Med 2001;161:441]
posted 2/22/2001
World
Trade Rules and Cheaper Drugs [Lancet 2001;357:243]
posted 2/22/2001
Increased
Mitochondrial Toxicity with Ribavirin in HIV/HCV Coinfection
[Lafeuillade A, et al. Lancet 2001;357:280]
posted 2/22/2001
Offers
of Low Cost Antiretroviral Medicines: A Statement from the World
Health Organization [WHO press release, www.who.int
2/9/01]
posted 2/22/2001
Gates
Gives Booster Shot to AIDS Vaccines [Science 2001;291:809]
posted 2/22/2001
Guidelines
for the Use of Antiretroviral Agents in HIV-Infected Adults and
Adolescents [www.hivatis.org]
posted 2/14/2001
|
archive